Ignite Creation Date:
2024-05-06 @ 3:02 AM
Last Modification Date:
2024-10-26 @ 11:27 AM
Study NCT ID:
NCT02187367
Status:
TERMINATED
Last Update Posted:
2019-09-10
First Post:
2014-07-07
Brief Title:
Safety Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive Wild Type EGF-R NSCLC Patients
Sponsor:
Organization:
Bioven Sdn Bhd